drugset / Trial / NCT03419715

Topical Bimatoprost in the Treatment of Migraine

NCT03419715

Phase 2 Unknown 70 enrolled Manistee Partners
RandomizedParallel-groupTriple-blindPrevention

Summary

The study is to assess the effectiveness of topically applied bimatoprost in reducing migraine headache frequency, severity, and duration. It will also assess the effect of topical bimatoprost on quality of life.

Timeline

Start
2018-01-05
Primary completion
2019-04-25
Completion
2019-06-30

Publications

  • Results Hall LB et al. The Effect of Topical Prostaglandins on Migraine Headaches. Poster Presentation at the Association for Research in Vision and Ophthalmology Annual Meeting, May 2017.

Drugs

EvaluationDrugModalityDoseRoute
Subject Bimatoprost Other / unclassified 0.03 %

Indications